Biomea Fusion Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Biomea Fusion Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- BMEA
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001840439
Board of directors
-
Bihua Chen · DirectorSince 2023
-
Elizabeth Faust · DirectorSince 2023
-
Eric Aguiar · DirectorSince 2023
-
Michael J.m. Hitchcock · Director · Interim CEOSince 2023
-
Rainer M. Erdtmann · Director · President and COOSince 2023
-
Sumita Ray · DirectorSince 2023
-
Thomas Andrew Butler · Director · Chief Executive OfficerSince 2023
Chief executives
Thomas Andrew Butler
· Chief Executive Officer
Dates unknown
Dates unknown
Board connections
2 of this board's directors also sit on 3 other boards.
- via Bihua Chen
- via Eric Aguiar
- via Bihua Chen
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 30, 2024 | Valle Franco Officer (Chief Financial Officer) | Grant or award | +495 | $6.15 | $3,044 |
| Sep 30, 2024 | Michael J.m. Hitchcock Director | Open-market purchase | +10,000 | $10.06 | $100,600 |
| Jun 11, 2024 | Valle Franco Officer (Chief Financial Officer) | Open-market purchase | +12,509 | $4.43 | $55,415 |
| May 31, 2024 | Valle Franco Officer (Chief Financial Officer) | Grant or award | +4,448 | $3.78 | $16,813 |
| May 31, 2024 | Frias Juan Pablo Officer (Chief Medical Officer) | Grant or award | +349 | $8.94 | $3,120 |
| Dec 29, 2023 | Rainer M. Erdtmann Director, Officer (President and COO) | Gift | −3,000 | — | — |
| Dec 29, 2023 | Rainer M. Erdtmann Director, Officer (President and COO) | Gift | +3,000 | — | — |
| Dec 29, 2023 | Rainer M. Erdtmann Director, Officer (President and COO) | Gift | −3,000 | — | — |
| Dec 29, 2023 | Rainer M. Erdtmann Director, Officer (President and COO) | Gift | +3,000 | — | — |
| Dec 29, 2023 | Rainer M. Erdtmann Director, Officer (President and COO) | Gift | −3,000 | — | — |
| Dec 29, 2023 | Rainer M. Erdtmann Director, Officer (President and COO) | Gift | +3,000 | — | — |
| Dec 29, 2023 | Rainer M. Erdtmann Director, Officer (President and COO) | Gift | −12,000 | — | — |
| Nov 30, 2023 | Valle Franco Officer (Chief Financial Officer) | Grant or award | +1,345 | $3.78 | $5,084 |
| Jun 1, 2023 | A2A Pharmaceuticals, Inc. 10% owner | Open-market sale | −50,000 | $34.56 | $1,728,000 |
| May 31, 2023 | Valle Franco Officer (Chief Financial Officer) | Grant or award | +4,273 | $3.78 | $16,152 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.